Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Orange 5379513, California 5332921
Dates
study started
study ends around
Principal Investigator
by Jason Samarasena, MD, MBA

Description

Summary

Peroral endoscopic myotomy (POEM) is an effective, minimally invasive treatment for achalasia, offering excellent rates of symptom relief. However, a significant drawback is the high incidence of gastroesophageal reflux disease (GERD) following the procedure. One proposed technical modification, the selective preservation of the sling fibers during gastric myotomy (SFP-POEM), may reduce this risk without compromising efficacy as compared to a conventional POEM procedure, which includes myotomy of the sling fibers. In this study, adults with achalasia will be randomly assigned to receive one of the two POEM technical approaches. Researchers will monitor whether preserving sling fibers reduces the rates of reflux esophagitis (classified as Los Angeles Grade B or higher) on follow-up endoscopy. Participants will be followed for up to 1 year after the procedure.

Details

Achalasia is a rare esophageal motility disorder treated effectively with peroral endoscopic myotomy (POEM). However, post-procedure gastroesophageal reflux disease (GERD) is a common complication, reported in up to 65% of cases. One proposed technical modification - the selective preservation of gastric sling fibers - may help reduce reflux by maintaining part of the native anti-reflux mechanism.

This is a single-blinded, multicenter randomized controlled trial comparing sling fiber preservation (SFP) POEM versus conventional POEM in adult patients with achalasia. Patients are randomized 1:1 to either technique. The primary endpoint is the incidence of significant reflux esophagitis (LA esophagitis grade B or higher) at 3 months post-procedure endoscopy. Secondary outcomes include acid exposure time on pH impedence monitoring, symptomatic reflux (GerdQ), PPI usage, technical and clinical success, and adverse events. Follow-up continues for 12 months.

The study aims to determine whether the SFP-POEM technique reduces acid reflux without compromising treatment efficacy.

Keywords

Achalasia, Esophageal, GERD (Gastroesophageal Reflux Disease), Achalasia, POEM, Peroral Endoscopic Myotomy, Sling Fiber Preservation, SFP-POEM, Gastroesophageal Reflux, GERD, Reflux Esophagitis, Randomized Controlled Trial, Esophageal Achalasia, Peptic Esophagitis, Sling Fiber-Preserving POEM, Sling Fiber-Preservation POEM

Eligibility

You can join if…

Open to people ages 18 years and up

(Participants must meet all of the following):

  • Age ≥ 18 years
  • Diagnosis of achalasia (Type I-III) per Chicago Classification v3.0
  • Deemed appropriate candidates for POEM
  • Ability to provide informed consent

You CAN'T join if...

(Participants will be excluded if any of the following apply):

  • Spastic motility disorders other than achalasia type I-III (e.g. diffuse esophageal spasm, jackhammer esophagus, EGJ outflow obstruction)
  • Sigmoid esophagus
  • Prior surgical myotomy (e.g., Heller myotomy)
  • Contraindications to endoscopy or general anesthesia
  • Pregnancy or actively breastfeeding
  • Significant cardiopulmonary comorbidities that preclude safe endoscopic intervention
  • Coagulopathy or portal hypertension
  • Unwillingness or inability to complete follow-up assessments

Location

  • University of California, Irvine - UCI Medical Center
    Orange 5379513 California 5332921 92868 United States

Lead Scientist at UC Irvine

  • Jason Samarasena, MD, MBA
    Clinical Professor, Medicine, School of Medicine. Authored (or co-authored) 101 research publications

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Irvine
ID
NCT07178821
Study Type
Interventional
Participants
Expecting 120 study participants
Last Updated